Study guide
Section 11.4: Disposal and Destruction of Controlled Substances
Texas MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pharmacy Law Foundations & Regulators
Section 1.1: State and Federal Regulatory Bodies Section 1.2: Structure of Texas Pharmacy Law Section 1.3: TSBP Powers and Administrative Procedures Section 1.4: Inspections, Investigations, and Discipline
2 Chapter 2: Pharmacist Licensure & Continuing Education
Section 2.1: Initial Pharmacist Licensure & Reciprocity Section 2.2: License Renewal & Continuing Education Requirements Section 2.3: Inactive Status, Reinstatement, and Administrative Changes Section 2.4: Impaired Pharmacists & Peer Review Programs
3 Chapter 3: Pharmacy Personnel & Supervision Ratios
Section 3.1: Pharmacist-in-Charge (PIC) Responsibilities and Duties Section 3.2: Pharmacy Technicians and Technician Trainees Section 3.3: Pharmacist-to-Technician Supervision Ratios Section 3.4: Duties of Supportive Personnel
4 Chapter 4: Pharmacy Permits & Facility Classifications
Section 4.1: Texas Pharmacy Permit Classes Section 4.2: Class A (Community) Operations & Facilities Section 4.3: Class C (Institutional/Hospital) Operations & Facilities Section 4.4: Central Processing (Class G) and Non-Resident (Class E)
5 Chapter 5: Prescribers & Prescription Validity
Section 5.1: Texas Prescriptive Authority Section 5.2: General Prescription Requirements Section 5.3: Out-of-State and Canadian/Mexican Prescriptions Section 5.4: Self-Prescribing & Prescribing for Family Members
6 Chapter 6: Controlled Substances Schedules & Registration
Section 6.1: Federal vs. Texas Controlled Substances Schedules Section 6.2: DEA Registration & Texas Controlled Substances Act Section 6.3: Scheduled Listed Chemical Products Section 6.4: Controlled Substance Theft or Loss Reporting
7 Chapter 7: Controlled Substances Prescriptions & Dispensing
Section 7.1: CII Prescription Requirements and Validity Section 7.2: CII Refills, Partial Fills, and Emergency Oral Dispensing Section 7.3: CIII-CV Prescription Requirements, Validity, Refills, and Partial Fills Section 7.4: Opioid 10-day Initial Supply Limit & PMP Mandatory Queries
8 Chapter 8: Prescription Monitoring Program (PMP) & Drug Abuse
Section 8.1: Texas Prescription Monitoring Program Reporting & Database Section 8.2: Naloxone Access and Standing Orders in Texas Section 8.3: Corresponding Responsibility & Red Flags of Diversion Section 8.4: Treatment of Substance Use Disorders
9 Chapter 9: Dispensing Standards & Generic Substitution
Section 9.1: Texas Generic Substitution Law Section 9.2: Patient Counseling and Drug Utilization Review Requirements Section 9.3: Prescription Labeling Requirements in Texas Section 9.4: Poison Prevention Packaging Act & Child-Resistant Containers
10 Chapter 10: Prescription Refills, Transfers & Emergency Dispensing
Section 10.1: Prescription Refill Refusal & Professional Judgment Section 10.2: Prescription Transfer Rules Section 10.3: Emergency Refills (72-hour rule & 30-day natural disaster rule) Section 10.4: Return and Reuse of Prescription Medications
11 Chapter 11: Pharmacy Operations, Security & Recordkeeping
Section 11.1: Pharmacy Security, Alarms & Delivery of Drugs in Texas Section 11.2: General Recordkeeping & Document Retention Requirements Section 11.3: Controlled Substance Inventories Section 11.4: Disposal and Destruction of Controlled Substances
12 Chapter 12: Compounding Standards (Sterile & Non-Sterile)
Section 12.1: Non-Sterile Compounding Regulations Section 12.2: Sterile Compounding Regulations Section 12.3: Hazardous Drug Handling Section 12.4: Compounding Recordkeeping & Quality Control
13 Chapter 13: Specialized Pharmacy Practice & Public Safety
Section 13.1: Collaborative Practice Agreements & Drug Therapy Management Section 13.2: Pharmacist Immunization Authority & Protocol Requirements Section 13.3: Automated Dispensing Devices (Class A, C, and remote sites) Section 13.4: Public Health Laws (HIPAA, OBRA-90, DSCSA Drug Track and Trace)
Section 11.4: Disposal and Destruction of Controlled Substances
Key Takeaways Explain This Topic AI
Sending expired inventory to a reverse distributor requires a DEA Form 222 for Schedule IIs and standard invoices for Schedule III-Vs.
Disposal of patient care wastage (partial doses) does not require a DEA Form 41, but requires a witness and medical record entry.
Under the Drug Disposal Act, pharmacy staff cannot handle patient returns; patients must deposit medications themselves.
Accidental, unrecoverable spillage or breakage is documented in the pharmacy log with two witness signatures, not on DEA Form 106.
DEA Form 41 is completed by the entity destroying the controlled substances, which is the reverse distributor in standard transfers.
Last updated: July 2026
Section 11.4: Disposal and Destruction of Controlled Substances
Proper disposal and destruction of controlled substances are heavily regulated to prevent environmental contamination and, most importantly, to prevent diversion of these highly abused medications. Texas pharmacists must master the distinct pathways for disposing of pharmacy inventory, patient wastage in hospitals, and patient-returned medications.
Disposal of Controlled Substance Inventory: Reverse Distributors
Pharmacies are generally prohibited from destroying controlled substance inventory on-site without prior written authorization from the DEA. The standard, preferred method for disposing of expired, damaged, or unwanted controlled substances in inventory is transferring them to a DEA-registered reverse distributor.
The Transfer Process
When a pharmacy sends controlled substances to a reverse distributor:
For Schedule II (CII) Drugs: The reverse distributor must issue a DEA Form 222 to the pharmacy. The pharmacy acts as the supplier (shipper) of the drugs, and the reverse distributor acts as the purchaser. The pharmacy must retain Copy 1 of the Form 222 (or document the electronic CSOS transaction) for 2 years.
For Schedule III-V (CIII-CV) Drugs: The transfer is documented using a standard invoice. The record must include the drug name, dosage form, strength, quantity, date of transfer, and the names, addresses, and DEA registration numbers of both the pharmacy and the reverse distributor.
Form 41 Responsibility: The reverse distributor (not the pharmacy) is responsible for destroying the substances and submitting DEA Form 41 (Registrants Inventory of Drugs Surrendered and Destroyed) to the DEA once the destruction is complete.
Disposal from Patient Care Areas (Wastage)
In hospital or institutional settings (Class C), a practitioner may prepare a controlled substance for administration but only administer a partial dose (e.g., wasting 0.5 mL of a 1 mL Morphine syringe).
Wastage Documentation Rules
No DEA Form 41 Required: Wastage from a patient care area is not considered a destruction of inventory and does not require the submission of a DEA Form 41.
Witness Requirement: The wastage must be witnessed by another licensed healthcare professional (such as a registered nurse, pharmacist, or physician).
Medical Record Logging: The date, time, drug name, strength, quantity wasted, and the signatures of both the administering practitioner and the witness must be documented in the patient's medical record, medication administration record (MAR), or a dedicated electronic wastage log.
Patient Take-Back Programs: The Secure and Responsible Drug Disposal Act
The Secure and Responsible Drug Disposal Act of 2010 allows pharmacies to voluntarily modify their DEA registration to become "authorized collectors" of controlled substances from ultimate users (patients, caregivers, or deceased patients' families).
Receptacle Security and Placement Rules
Authorized collectors can install physical collection receptacles (dropboxes) in their pharmacies. The receptacle must meet strict security standards:
Construction: Must be securely fastened to a permanent structure (such as the floor or wall) and constructed of sturdy, tamper-resistant material.
Double-Lock System: Must have a outer container that is locked, and inside, a removable, waterproof, tamper-evident liner.
Location: Must be located within the physical building of the pharmacy and in the immediate vicinity of the pharmacy counter, where it can be actively monitored by pharmacy staff. It must not be placed inside the locked prescription department where the public cannot access it, nor can it be placed outside the pharmacy building.
Signage: Must have clear signage indicating that only non-controlled and Schedules II-V controlled substances are accepted (no needles, medical waste, or illicit street drugs).
The Critical "No-Touch" Rule
Pharmacy Staff Prohibition: Pharmacy employees are strictly prohibited from touching, handling, sorting, or disposing of a patient's returned medications.
Patient Placement: The patient or caregiver must place the medications directly into the collection receptacle.
Liner Handling: When the inner liner is full, it must be removed and sealed immediately by two pharmacy employees. The sealed liner must be documented and stored in a secure cabinet until it is transferred to a reverse distributor for destruction. The contents of the liner must never be opened, counted, or inspected.
Spillage, Breakage, and Unrecoverable Losses
Occasionally, controlled substances are broken or spilled. The legal handling of these incidents depends on whether the drug is recoverable.
1. Recoverable Spillage/Breakage
If a bottle of liquid morphine breaks but the liquid can be recovered (e.g., absorbed in paper towels or kept in the broken glass), it is considered damaged inventory.
The pharmacy must send the recovered material to a reverse distributor or request permission from the DEA to destroy it on-site using DEA Form 41 .
2. Unrecoverable Spillage/Breakage
If a vial of fentanyl drops on the floor and shatters, and the liquid is completely absorbed into the floor tiles or washed away, it is unrecoverable.
No DEA Form 41: Since the drug cannot be surrendered, a DEA Form 41 is not appropriate.
No DEA Form 106: Since the drug was not stolen or lost in transit, a DEA Form 106 (Theft or Loss) is not used.
Logging Procedure: The incident must be documented in the pharmacy's records. The entry must describe the accident, state the quantity lost, and be signed by the pharmacist on duty and at least one witness (e.g., a technician or another staff member).
Texas MPJE Exam Warnings & Legal Traps
Warning
The Employee Assistance Trap: A common exam scenario involves an elderly patient handing a bag of old pain medications to a pharmacy technician to put in the disposal bin. Under DEA rules, the technician cannot accept or touch the bag. The technician must instruct the patient to drop it into the slot themselves.
Important
Form 41 vs. Form 106: Always remember:
DEA Form 41 = Planned destruction of inventory (Registrant Surrender).
DEA Form 106 = Unplanned theft or significant loss.
Spilled or broken drugs that are unrecoverable do not require either form; they require a local log entry with witness signatures.